BMC infectious diseases

[1] A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.

[2] A cross-sectional study of tuberculosis drug resistance among previously treated patients in a tertiary hospital in Accra, Ghana: public health implications of standardized regimens.

[3] paclitaxel with cisplatin as salvage treatment for patients with previously treated advanced transitional cell carcinoma of the urothelial tract

[4] gefitinib frequently induces liver damage in patients with lung adenocarcinoma previously treated by chemotherapy

[5] efficacy of a preservative-free formulation of fixed-combination bimatoprost and timolol (ganfort pf) in treatment-naïve patients vs previously treated patients

[6] first insight into a nationwide genotypic diversity of mycobacterium tuberculosis among previously treated pulmonary tuberculosis cases in benin, west africa

[7] improved compliance and patient satisfaction with estradiol vaginal tablets in postmenopausal women previously treated with another local estrogen therapy

[8] a retrospective analysis of vinorelbine chemotherapy for patients with previously treated soft-tissue sarcomas

[9] the efficacy and safety of nivolumab in previously treated advanced non-small-cell lung cancer: a meta-analysis of prospective clinical trials

[10] characteristics of foot fractures in hiv-infected patients previously treated with tenofovir versus non-tenofovir-containing highly active antiretroviral therapy

[11] Daratumumab plus pomalidomide and dexamethasone versus pomalidomide and dexamethasone alone in previously treated multiple myeloma (APOLLO): an open-label, randomised, phase 3 trial